NCT06599437

Brief Summary

The goal of this clinical trial is to learn if early laparoscopic cholecystectomy is safe and feasible when performed during the same admission for patients with concomitant gallbladder and common bile duct stones after clearance of CBD stones via ERCP in comparison to Late laparoscopic cholecystectomy 6 weeks after ERCP. The main questions it aims to answer are: laparoscopic cholecystectomy

  • Does index laparoscopic cholecystectomy associate with less recurrence of biliary complications?
  • Is index laparoscopic cholecystectomy feasible and safe for the patients in terms of intraoperative difficulties, conversion to open, hospital stay, and postoperative complications than late laparoscopic cholecystectomy? the investigator will compare index laparoscopic cholecystectomy with late laparoscopic cholecystectomy 6 weeks after ERCP to see if index laparoscopic cholecystectomy is safe and feasible and associated with better outcomes. Participants will: Come to the outpatient clinic every week after intervention for follow-up for 3 months after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2021

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2024

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

September 7, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

2.3 years

First QC Date

September 7, 2024

Last Update Submit

September 16, 2024

Conditions

Keywords

choledocholithiasisERCPEarly cholecystectomy

Outcome Measures

Primary Outcomes (1)

  • recurrence of biliary events

    the occurence of acute cholecystitism biliary colics, common bile duct stonem pancreatitisand cholangitis after ERCP while waiting for laparoscopic cholecystectomy

    up to 3 months after surgery

Secondary Outcomes (9)

  • operative time

    during surgery

  • pancreatitis

    3 months after surgery

  • conversion to open surgery

    During surgery

  • Bleeding

    during surger and up to 3 weeks

  • the presence of intraoperative adhesions

    During surgery

  • +4 more secondary outcomes

Study Arms (2)

Early same admission laparoscopic cholecystectomy ( group A)

ACTIVE COMPARATOR

Early laparoscopic cholecystectomy is performed on next day within 24 hours after common bile duct stone removal by ERCP.

Procedure: laparoscopic cholecystectomy

Late laparoscopic cholecystectomy ( group B)

ACTIVE COMPARATOR

Late laparoscopic cholecystectomy is performed 6 weeks after common bile duct stones clearance

Procedure: Late laparoscopic cholecystectomy

Interventions

Early laparoscopic cholecystectomy in the same admission after atone clearance from the bile ducts via ERCP.

Early same admission laparoscopic cholecystectomy ( group A)

Laparoscopic cholecystectomy is performed 6 weeks after clearance of stones from the common bile duct.

Late laparoscopic cholecystectomy ( group B)

Eligibility Criteria

AgeUp to 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with concomitant gallbladder and common bile duct stone who underwent clearance of common bile duct stones by ERCP

You may not qualify if:

  • Severe pancreatitis
  • Suspicion of post-ERCP bleeding or perforation,
  • Associated malignancy
  • Those in whom ERCP failed to clear the CBD stones

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Damanhur Medical National Institute

Damanhur, Behira, 22951, Egypt

Location

MeSH Terms

Conditions

Choledocholithiasis

Interventions

Cholecystectomy, Laparoscopic

Condition Hierarchy (Ancestors)

Common Bile Duct DiseasesBile Duct DiseasesBiliary Tract DiseasesDigestive System DiseasesCholelithiasis

Intervention Hierarchy (Ancestors)

CholecystectomyBiliary Tract Surgical ProceduresDigestive System Surgical ProceduresSurgical Procedures, OperativeLaparoscopyEndoscopyMinimally Invasive Surgical Procedures

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Hepatopacreatobiliary and GI Surgery

Study Record Dates

First Submitted

September 7, 2024

First Posted

September 19, 2024

Study Start

December 1, 2021

Primary Completion

April 1, 2024

Study Completion

August 15, 2024

Last Updated

September 19, 2024

Record last verified: 2024-09

Locations